title: Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study.
authors.affiliation: Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
authors.forename: M R
authors.initials: MR
authors.lastname: Grever
authors.forename: J
authors.initials: J
authors.lastname: Crowley
authors.forename: S
authors.initials: S
authors.lastname: Salmon
authors.forename: R
authors.initials: R
authors.lastname: McGee
authors.forename: E H
authors.initials: EH
authors.lastname: Kraut
authors.forename: S S
authors.initials: SS
authors.lastname: Buys
authors.forename: S E
authors.initials: SE
authors.lastname: Rivkin
mesh_terms: D000368:Aged; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D015649:Pentostatin / Q000627:therapeutic use* / Q000633:toxicity
chemical_list: D015649:Pentostatin; D003404:Creatinine